|
|

|
|
Routine screening for lung cancer
not necessary
17 September, 2007
The American College of Chest
Physicians (ACCP) has released
guidelines indicating that routine
screening for lung cancer with
computerized tomography (CT) scanning
and other methods are generally not
warranted outside of research studies.
In a larger, accompanying report, the
ACCP lists 260 recommendations that
should be followed in the prevention,
screening, diagnosis, staging, and
treatment of lung cancer.
Both sets of guidelines, prepared by
100 multi-disciplinary members of the
American College of Chest Physicians,
have been published in a supplement to
the journal Chest.
After reviewing findings of previous
studies, the research team, led by Dr
Peter B Bach, from Memorial
Sloan-Kettering Cancer Center in New
York, the United States, concluded
that screening with CT imaging or
certain sputum tests simply did not
reduce lung cancer deaths, even in
high-risk groups, such as heavy
smokers.
According to the investigators, one of
the problems is that current research
on CT and sputum screening has focused
primarily on lung cancer detection
rates, not on whether patient outcomes
are actually improved. Studies
addressing this question are under
way, but the answers will not be
available for years.
Based on a lack of solid evidence
supporting the following practices,
the American College of Chest
Physicians makes three
recommendations:
- Do not use
CT to screen for lung cancer outside
of trial settings.
- Do not use
chest X-rays to screen for lung
cancer.
- Do not use
sputum tests to screen for lung
cancer.
According to Gene L Colice,
vice-chairman of the ACCP lung cancer
guidelines, population screening for
lung cancer is not recommended and
may, ultimately, put the patient at
risk for further complications.
Dr W Michael Alberts, Chief Medical
Officer of H Lee Moffitt Cancer Center
and Research Institute, Tampa,
Florida, the United States, cautioned
that even in high-risk populations,
research data currently available do
not show that lung cancer screening
alters mortality outcomes.
The ACCP guidelines also advise
against the use of vitamins,
particularly beta-carotene, vitamin A,
and vitamin E, as a means of
preventing lung cancer. Use of case of
beta-carotene may actually increase
the risk of the cancer.
According to the report, there is also
no solid evidence that aspirin helps
prevent lung cancer or reduces lung
cancer deaths.
By contrast, for the first time, the
ACCP guidelines support the use of
certain alternative treatments as in
addition to conventional therapy.
Massage therapy is recommended when
anxiety or pain is present, and
acupuncture is advised for fatigue,
shortness of breath, and poorly
controlled nausea and vomiting.
|
|
|